Insulet | PODD - Operating Expenses

Stock Price
347.25
Daily Change
-1.18 -0.34%
Monthly
25.23%
Yearly
61.70%
Q3 Forecast
345.54

Insulet reported $528M in Operating Expenses for its fiscal quarter ending in June of 2025.




Operating Expenses Change Date
Abbott USD 9.07B 369M Jun/2025
Align Technology USD 849.42M 1.25M Jun/2025
AtriCure USD 142.33M 12.76M Jun/2025
Avanos Medical USD 228.66M 71.46M Jun/2025
Baxter International USD 2.54B 29M Jun/2025
Becton, Dickinson and Co. USD 4.53B 196M Jun/2025
Boston Scientific USD 4.12B 377M Jun/2025
Cardinal Health USD 59.53B 5.38B Jun/2025
Cooper Companies USD 884.6M 67.1M Jul/2025
Dexcom USD 944.5M 42.2M Jun/2025
Edwards Lifesciences USD 1.1B 83.4M Jun/2025
Eli Lilly USD 8.54B 1.22B Jun/2025
Globus Medical USD 1.62B 1.12B Jun/2025
ICU Medical USD 522.06M 53.06M Jun/2025
Insulet USD 528M 8.3M Jun/2025
Integra LifeSciences USD 416.91M 18.3M Jun/2025
J&J USD 16.8B 8.54B Jun/2025
Masimo USD 306.4M 12.4M Jun/2025
Medtronic USD 7.06B 430M Jul/2025
Merit Medical Systems USD 335.44M 21.12M Jun/2025
Roche Holding CHF 11.43B 1.48B Dec/2024
Solventum Corp 1.95B 29M Jun/2025
Stryker USD 4.85B 175M Jun/2025
Tandem Diabetes Care USD 272.54M 82.76M Jun/2025
Teleflex USD 603.41M 33.06M Jun/2025
West Pharmaceutical Services USD 612.8M 21.8M Jun/2025
Zimmer Biomet Holdings USD 1.68B 110.7M Jun/2025